Search

Peter G Klimko

from Fort Worth, TX
Age ~59
Get Report
Also known as:
Peter Gerard Klimko, Peter G Klinko, Peter G Kilmko
Phone and address:
2115 Pembroke Dr, Fort Worth, TX 76110
(817) 926-3606
Related to:
Constance Joan Klimko, 59Mary Klimko, 61Charles KileyCharles Klimko, 63Mary Shelton, 61
Connected to:
Lisa L Klimko, 63Sarah J Klimko, 40Karen M Klimkos, 68Brian Klimkowski, 36Donald G Klimkowicz, 69Kenneth J Klimkowski, 56Amy J Klimoski, 45Richard Klimoski, 66Victoria Klimova, 27Vladislav A Klimov, 51

Peter Klimko Phones & Addresses

  • 2115 Pembroke Dr, Fort Worth, TX 76110 (817) 926-3606
  • Ft Worth, TX
  • Rockbridge, OH
  • Durham, NC
  • Pittsboro, NC
  • Coatesville, PA
  • Millsap, TX
  • Paoli, PA
  • Exton, PA
  • Limerick, PA
  • 2115 Pembroke Dr, Fort Worth, TX 76110

Work

Company: Novartis Jan 2017 Position: Global program team director, pharmaceutical development

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Texas A&M University 1987 to 1991 Specialities: Organic Chemistry

Skills

Pharmaceutical Industry • Hplc • Lifesciences • Biotechnology • Medicinal Chemistry • Chemistry • Organic Synthesis • Organic Chemistry • R&D • Drug Design • Biochemistry • Drug Discovery • Drug Delivery • Life Sciences • Drug Development • Pharmacology • Assay Development • Analytical Chemistry • Clinical Research • Chromatography • Clinical Development • Clinical Trials • Cell • Cro

Industries

Pharmaceuticals

Resumes

Resumes

Peter Klimko Photo 1

Global Program Team Director, Pharmaceutical Development

View page
Location:
Chicago, IL
Industry:
Pharmaceuticals
Work:
Novartis
Global Program Team Director, Pharmaceutical Development
Alcon, A Novartis Company Jun 1, 2013 - Dec 2016
Project Head, Pharmaceutical Development Group
Novartis Institutes For Biomedical Research (Nibr) 2011 - 2013
Assistant Director
Alcon, A Novartis Company 1993 - 2011
Senior Scientist
Bryn Mawr College 1992 - 1993
Postdoctoral Researcher
Education:
Texas A&M University 1987 - 1991
Doctorates, Doctor of Philosophy, Organic Chemistry The Ohio State University 1983 - 1987
Bachelors, Bachelor of Science, Chemistry
Skills:
Pharmaceutical Industry
Hplc
Lifesciences
Biotechnology
Medicinal Chemistry
Chemistry
Organic Synthesis
Organic Chemistry
R&D
Drug Design
Biochemistry
Drug Discovery
Drug Delivery
Life Sciences
Drug Development
Pharmacology
Assay Development
Analytical Chemistry
Clinical Research
Chromatography
Clinical Development
Clinical Trials
Cell
Cro

Publications

Us Patents

Benzenoid Derivatives Of 15-Hydroxyeicosatetraenoic Acid And Methods Of Their Use In Treating Dry Eye Disorders

View page
US Patent:
6342525, Jan 29, 2002
Filed:
Oct 23, 2000
Appl. No.:
09/694614
Inventors:
Peter G. Klimko - Fort Worth TX
David R. Pierce - Fort Worth TX
Assignee:
Alcon Universal Ltd. - Hunenberg
International Classification:
A01N 3710
US Classification:
514532, 514570, 560 55, 560 60, 562465, 562470
Abstract:
Benzenoid HETE derivatives and methods of their use for treating dry eye are disclosed.

Method Of Prostaglandin Synthesis

View page
US Patent:
6344581, Feb 5, 2002
Filed:
Oct 31, 1997
Appl. No.:
08/962200
Inventors:
Raymond E. Conrow - Crowley TX
Paul W. Zinke - Fort Worth TX
Peter G. Klimko - Fort Worth TX
Robert D. Selliah - Forth Worth TX
Assignee:
Alcon Manufacturing, Ltd. - Fort Worth TX
International Classification:
A61K 31557
US Classification:
560118, 562500
Abstract:
Methods of synthesizing 9-Halo-13,14-dihydroprostaglandins useful in the treatment of glaucoma and ocular hypertension are disclosed. Also disclosed are ophthalmic, pharmaceutical compositions comprising such prostaglandins.

11-Halo Prostaglandins For The Treatment Of Glaucoma Or Ocular Hypertension

View page
US Patent:
6353000, Mar 5, 2002
Filed:
Jun 2, 1999
Appl. No.:
09/284533
Inventors:
Verney L. Sallee - Burleson TX
Mark R. Hellberg - Arlington TX
Peter G. Klimko - Fort Worth TX
Paul W. Zinke - Fort Worth TX
Assignee:
Alcon Laboratories, Inc. - Fort Worth TX
International Classification:
A01N 4316
US Classification:
514310, 549399, 549401, 549429, 560129, 562503
Abstract:
A method of treating glaucoma or ocular hypertension in a patient, which comprises administering to the patient a pharmaceutically effective amount of a compound of formula I:.

15-Hydroxyeicosatetraenoic Acid-Related Compounds And Methods Of Use

View page
US Patent:
6353012, Mar 5, 2002
Filed:
Oct 23, 2000
Appl. No.:
09/694713
Inventors:
Mark R. Hellberg - Arlington TX
John M. Yanni - Burleson TX
Gustav Graff - Cleburne TX
Daniel A. Gamache - Arlington TX
Peter G. Klimko - Fort Worth TX
Assignee:
Alcon Universal Ltd. - Hunenberg
International Classification:
A61K 3141
US Classification:
514381, 514529, 514546, 514547, 514549, 514550, 514551, 514557, 514578, 514613, 548215, 548753, 560181, 560182, 560184, 560187, 562579, 562581, 562582, 562586, 562588, 562595, 562598, 564199, 564201, 564204, 564209
Abstract:
HETE derivatives and methods of their use for treating dry eye are disclosed.

15-Ketal Postaglandins For The Treatment Of Glaucoma Or Ocular Hypertension

View page
US Patent:
6353014, Mar 5, 2002
Filed:
Jun 2, 1999
Appl. No.:
09/284534
Inventors:
Verney L. Sallee - Burleson TX
Mark R. Hellberg - Arlington TX
Peter G. Klimko - Fort Worth TX
Assignee:
Alcon Laboratories, Inc. - Fort Worth TX
International Classification:
A01N 4338
US Classification:
514414, 514305, 514306, 514307, 514309, 514310, 514412, 514416, 514432, 514443, 514456, 514461, 514463, 514464, 514465, 514467, 546429, 546134, 548452, 548469, 548470, 548482, 549 49, 549 51, 549 57, 549 78, 549398, 549399
Abstract:
A method of treating glaucoma or ocular hypertension in a patient, which comprises administering to the patient a pharmaceutically effective amount of a compound of formula I:.

Phospholipids Of Hydroxyeicosatetraenoic Acid-Like Derivatives And Methods Of Use

View page
US Patent:
6353032, Mar 5, 2002
Filed:
Oct 23, 2000
Appl. No.:
09/694138
Inventors:
Gustav Graff - Cleburne TX
Peter G. Klimko - Fort Worth TX
Assignee:
Alcon Universal Ltd. - Hunenberg
International Classification:
A61K 3119
US Classification:
514912, 514914, 514572, 514573, 554 40, 554701, 554 42
Abstract:
Phospholipid-HETE derivatives, compositions and methods of use are disclosed. The compounds are particularly useful for treating dry eye.

13-Aza Prostaglandins For The Treatment Of Glaucoma And Ocular Hypertension

View page
US Patent:
6417228, Jul 9, 2002
Filed:
Oct 29, 1999
Appl. No.:
09/430513
Inventors:
Peter G. Klimko - Fort Worth TX
Assignee:
Alcon Manufacturing, Ltd.. - Fort Worth TX
International Classification:
A61K 31215
US Classification:
514530, 514573, 560 48, 562457
Abstract:
13-Aza analogs of PGF and methods of their use in treating glaucoma and ocular hypertension are disclosed.

Heteroatom-Interrupted Analogs Of 15-Hydroxyeicosatetraenoic Acid And Methods Of Use

View page
US Patent:
6436994, Aug 20, 2002
Filed:
Jun 25, 2001
Appl. No.:
09/891357
Inventors:
Raymond E. Conrow - Crowley TX
Peter G. Klimko - Fort Worth TX
Assignee:
Alcon Universal Ltd. - Hunenberg
International Classification:
A01N 3706
US Classification:
514549, 560174, 560179, 560183, 562577, 562579
Abstract:
Heteroatom-interrupted HETE derivatives and methods of their use for treating dry eye are disclosed.
Control profile
Peter G Klimko from Fort Worth, TX, age ~59 Get Report